Dominic Smethurst is Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 70,807 shares of CRBP, which is worth approximately $472,282. The most recent transaction as insider was on Mar 06, 2025, when has been sold 6,393 shares (Common Stock, par value $0.0001 per share) at a price of $6.78 per share, resulting in proceeds of $43,344. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.8K
41.61% 3M change
41.61% 12M change
Total Value Held $472,282

Dominic Smethurst Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2025
SELL
Open market or private sale
$43,344 $6.78 p/Share
6,393 Reduced 8.28%
70,807 Common Stock, par valu...
Jan 31 2025
BUY
Grant, award, or other acquisition
-
27,200 Added 26.05%
77,200 Common Stock, par valu...
Feb 27 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 50.0%
50,000 Common Stock, par valu...

Also insider at

BCYC
BICYCLE THERAPEUTICS plc Healthcare
DS

Dominic Smethurst

Chief Medical Officer
Cambridge, X0

Track Institutional and Insider Activities on CRBP

Follow Corbus Pharmaceuticals Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBP shares.

Notify only if

Insider Trading

Get notified when an Corbus Pharmaceuticals Holdings, Inc. insider buys or sells CRBP shares.

Notify only if

News

Receive news related to Corbus Pharmaceuticals Holdings, Inc.

Track Activities on CRBP